Noveko International Announces a pre-IDE Meeting with the FDA to Consider an Additional Labelling Claim for its Noveko(TM) Masks and Respirators


    MONTREAL, Sept. 11 /CNW Telbec/ - Noveko International Inc. ("the
Company") is pleased to announce that further to its request, the Food and
Drugs Administration (the "FDA") accepted to meet with the Company, to
consider an additional labelling claim for its Noveko(TM) masks and
respirators. At a formal pre-IDE (investigational device exemption) meeting
with the FDA held earlier this week, both parties held discussions with
respect to this additional claim which would allow the Noveko(TM) masks and
respirators to be marketed as a medical device reducing exposure to airborne
influenza particles.
    Dialogue is continuing with the FDA in order for the Company to obtain
clarifications and guidelines for providing the supportive data for a future
submission by the Company to market in the US its Noveko(TM) masks and
respirators with an antiviral claim.
    Simultaneously, the process is continuing regarding the current pending
510(k) submission for the Noveko(TM) 3xEZ Antibacterial Surgical Mask.


    Noveko International Inc. offers innovative solutions in the
environmental and medical fields worldwide. Through its subsidiaries, the
Company specializes primarily in the following business segments: the
development, manufacturing and marketing of derivative products from its
patented antimicrobial filtration technology, including air filters, surgical
masks and respirators, along with other products with antimicrobial properties
such as AZURO(TM) antiseptic disinfectants - and the development,
manufacturing and marketing of medical equipment, primarily portable real-time
ultrasound scanners for use in human and veterinary medicine.

    Certain statements set forth in this press release constitute
forward-looking statements. In some cases, these statements are identified by
the use of terms such as "may", "could", "might", "intend", "should",
"expect", "project", "plan", "believe", "estimate" or other comparable
variants. These statements are based on the information available at the time
they are written, on assumptions made by management and on the expectations of
management, acting in good faith, regarding future events, including those
relating to economic conditions, fluctuations in exchange rates and operating
expenses, and the absence of unusual events entailing supplementary
expenditures. Although management considers these assumptions and expectations
reasonable based on the information available at the time they are written,
they could prove inaccurate. Forward-looking statements are also subject, by
their very nature, to known and unknown risks and uncertainties such as those
related to the industry, acquisitions, labor relations, credit, key officers,
supply and product liability. The actual results of Noveko International Inc.
could differ materially from those indicated or underlying these
forward-looking statements. The reader is therefore recommended not to unduly
rely on these forward-looking statements. Forward-looking statements do not
reflect the potential impact of special items, any business combination or any
other transaction that may be announced or occur subsequent to the date
hereof. The Company undertakes no obligation to update or revise the
forward-looking statements to account for new events or new circumstances,
except where provided for by applicable legislation.

For further information:

For further information: Chantal Vennat, Director, Investor Relations
and Corporate Communications, Noveko International Inc., (514) 875-0606;

Organization Profile

Noveko International Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890